Search
Filter Results
Displaying 1–10 of 193 for “x-linked”
-
X-linked retinoschisis (XLRS) is an inherited retinal disease causing vision loss due to splitting of the layers of the retina.
-
Aug 4, 2015
A Surprising Number of Carrier Females are Affected by X-Linked Retinitis Pigmentosa
40 percent of genetically tested XLRP carriers showed a definitive abnormality in at least one of three visions tests.
-
Oct 18, 2021
Atsena Therapeutics Developing X-Linked Retinoschisis Gene Therapy
The emerging gene therapy is being designed to more safely reach the fovea
-
Jan 18, 2022
Survey results will inform therapy developers and the agenda for a Patient-Focused Drug Development meeting with Food and Drug Administration representatives.
-
Apr 25, 2022
Webinar for the X-Linked Retinitis Pigmentosa (XLRP) Community
The Foundation Fighting Blindness recently held a webinar to provide details about an upcoming Externally-Led Patient Focused Drug Development (EL-PFDD) meeting for XLRP, and to provide background information about the Food and Drug Administration’s (FDA) drug review process.
-
X-linked retinoschisis (XLRS) is an inherited retinal diseasing causing vision loss due to splitting of the layers of the retina.
-
Often diagnosed in childhood or adolescence, retinitis pigmentosa (RP) is an inherited retinal disease causing progressive loss of night and peripheral vision. The condition often leads to legal and sometimes complete blindness.
-
Choroideremia is an inherited retinal disease that causes progressive vision loss due to degeneration of the choroid, the retinal pigment epithelium or RPE, and the photoreceptors.
-
Oct 10, 2014
Genetics 101: How Some Retinal Diseases are Inherited
To understand heredity, you have to know a little about genetics. Below is a review of the three major genetic-disease inheritance patterns.
-
May 20, 2022
Foundation Insights Forum – May 13, 2022
The Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the inherited retinal disease community. The call took place on May 13, 2022.